Blood Typing: Market is Expanding With Growing Demand in Forensic Science

Blood Group Typing Market by Product (Consumable (Anti-sera), Instrument, Service), Test Type (ABO, Antigen, Antibody Screening, Cross Matching, HLA), Technique (Assay, PCR, Microarray, Massively Parallel Sequencing), End User.

Market Revenue Growth and Key Factors:

1. Increasing Number of Blood Donations
2. Increasing Demand for Blood Group Typing in Prenatal Testing
3. Increasing Usage of Blood Group Typing in Forensic Sciences
4. Blood Group Typing With Molecular Diagnostics

The blood group typing market is projected to reach USD 3.12 billion by 2021 from USD 1.95 billion in 2016, at a CAGR of 9.8%.

Download PDF Brochure:

Market Segment Analysis:

Based on technique, the market is segmented into PCR-based and microarray techniques, assay-based techniques, massively parallel sequencing, and other techniques. The PCR-based and microarray techniques segment is expected to grow at the highest CAGR during the forecast period. The large share and high growth of this segment can be attributed to the rising prevalence of chronic diseases and increasing R&D activities focused on understanding the molecular basis of blood and antibody-antigen interactions.

Based on the end user, the market is segmented into hospitals, blood banks, clinical laboratories, and other end users. The hospitals end-user segment is expected to grow at the highest CAGR during the forecast period. This growth can be attributed to the increasing awareness on blood donations and their importance, rising number of blood donations, and growing requirement of blood in surgical treatments.

Regional Growth Analysis and Key Players:

Geographically, the market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). Some of the major players in the market are Bio-Rad Laboratories, Inc. (U.S.), Grifols, S.A. (Spain), Immucor, Inc. (U.S.), Ortho Clinical Diagnostics, Inc. (U.S.), Quotient, Ltd. (U.S.), ), Novacyt Group (France), BAG Healthcare GmbH (Germany), Rapid Labs (U.K.), Day medical SA (Switzerland), DIAGAST (France), and AXO Science (France).